Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 24, 2013 - Issue 3
Submit an article Journal homepage
1,001
Views
49
CrossRef citations to date
0
Altmetric
Psoriasis

Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis

Shiu-Chung AuDepartment of Dermatology, Tufts Medical Center, Boston, MA, USACorrespondence[email protected]
,
Ari M. GoldminzTufts University School of Medicine, Boston, MA, USA
,
Noori KimDepartment of Dermatology, Tufts Medical Center, Boston, MA, USA
,
Nicole DumontDepartment of Dermatology, Tufts Medical Center, Boston, MA, USA
,
Melissa MichelonDepartment of Dermatology, Tufts Medical Center, Boston, MA, USA
,
Eva VolfDepartment of Dermatology, Tufts Medical Center, Boston, MA, USA
,
Meghan HessionDepartment of Dermatology, Tufts Medical Center, Boston, MA, USA
,
Paul F. LizzulDepartment of Dermatology, Tufts Medical Center, Boston, MA, USA
,
Israel D. AndrewsDepartment of Dermatology, Tufts Medical Center, Boston, MA, USA
,
Todd KerenskyDepartment of Dermatology, Tufts Medical Center, Boston, MA, USA
,
Andrew WangDepartment of Dermatology, Tufts Medical Center, Boston, MA, USA
,
Shimrat YanivDepartment of Dermatology, Tufts Medical Center, Boston, MA, USA
&
Alice B. GottliebDepartment of Dermatology, Tufts Medical Center, Boston, MA, USA;Tufts University School of Medicine, Boston, MA, USA
 show all
Pages 179-187 | Received 03 Jan 2012, Accepted 06 Feb 2012, Published online: 08 May 2012

Citations (49)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Luciano Ibba, Luigi Gargiulo, Angela Alfano, Ruggero Cascio Ingurgio, Alessandra Narcisi, Antonio Costanzo & Mario Valenti. (2023) Anti-IL-23 and anti-IL-17 drugs for the treatment of non-pustular palmoplantar psoriasis: a real-life retrospective study. Journal of Dermatological Treatment 34:1.
Read now
Jia-Ming Xu, Hai-Meng Wang & Hong-Zhong Jin. (2023) An update on therapeutic options for palmoplantar pustulosis: a narrative review and expert recommendations. Expert Review of Clinical Immunology 19:5, pages 499-516.
Read now
Egídio Freitas, Maria Alexandra Rodrigues & Tiago Torres. (2020) Diagnosis, Screening and Treatment of Patients with Palmoplantar Pustulosis (PPP): A Review of Current Practices and Recommendations. Clinical, Cosmetic and Investigational Dermatology 13, pages 561-578.
Read now
Wen-Ming Wang & Hong-Zhong Jin. (2020) Biologics in the treatment of pustular psoriasis. Expert Opinion on Drug Safety 19:8, pages 969-980.
Read now
Dario Kivelevitch, Jillian Frieder, Ian Watson, So Yeon Paek & M. Alan Menter. (2018) Pharmacotherapeutic approaches for treating psoriasis in difficult-to-treat areas. Expert Opinion on Pharmacotherapy 19:6, pages 561-575.
Read now

Articles from other publishers (44)

Giacomo Caldarola, Gennaro Marco Falco, Laura Calabrese, Alessandra D'Amore, Andrea Chiricozzi, Marco Mariani, Gerardo Palmisano, Clara De Simone & Ketty Peris. (2023) Drug survival of biologics and non‐biologics in patients affected by palmoplantar psoriasis: a “real‐world”, mono‐center experience. International Journal of Dermatology.
Crossref
Kalpana R Naramwar & Varsha N Sane. (2023) THE ROLE OF JALAUKAVACHARAN IN VIPADIKA - A SINGLE CASE STUDY. International Ayurvedic Medical Journal 11:10, pages 2602-2605.
Crossref
Lihua Ye, Zhenfei Wu, Changrong Li, Xiaoxia Zhao, Mengjie Wan & Li Wang. (2022) Off‐label uses of ustekinumab. Dermatologic Therapy 35:12.
Crossref
Vipawee S. Chat, Shelley K. Uppal, Donovan G. Kearns & Jashin J. Wu. (2021) Comparison of guidelines for the use of Ustekinumab for psoriasis in the United States, Europe, and the United Kingdom: A critical appraisal and comprehensive review. Dermatologic Therapy 34:4.
Crossref
Jeffrey J. Crowley. 2021. Advances in Psoriasis. Advances in Psoriasis 343 362 .
Magdalena Misiak-Galazka, Joanna Zozula & Lidia Rudnicka. (2020) Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments. American Journal of Clinical Dermatology 21:3, pages 355-370.
Crossref
A.B. GottliebA. Kubanov, M. Doorn, J. Sullivan, K.A. Papp, R. You, P. Regnault & J.A. Frueh. (2019) Sustained efficacy of secukinumab in patients with moderate‐to‐severe palmoplantar psoriasis: 2·5‐year results from GESTURE , a randomized, double‐blind, placebo‐controlled trial . British Journal of Dermatology 182:4, pages 889-899.
Crossref
Nora Kogan, Nélida Raimondo, Simon E. Gusis, Ariel Izcovich, Jorge A. Abarca Duran, Lilia Barahona‐Torres, Orestes Blanco, Gerardo B. Quintana, María C. Briones, Carla Castro, Evelyn G. Castro Vargas, Juan Criniti, Juan C. Diez de Medina, Manuel Franco, Minerva Gómez, Patricia Levrero, Jaime E. Martínez López & Fernando Valenzuela. (2019) Latin American Clinical Practice Guidelines on the Systemic Treatment of Psoriasis SOLAPSO – Sociedad Latinoamericana de Psoriasis (Latin American Psoriasis Society) . International Journal of Dermatology 58:S1, pages 4-28.
Crossref
Alan Menter, Bruce E. Strober, Daniel H. Kaplan, Dario Kivelevitch, Elizabeth Farley Prater, Benjamin Stoff, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Dawn M.R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Arthur Kavanaugh, Matthew Kiselica, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Reena N. Rupani, Michael Siegel, Emily B. Wong, Jashin J. Wu, Vidhya Hariharan & Craig A. Elmets. (2019) Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. Journal of the American Academy of Dermatology 80:4, pages 1029-1072.
Crossref
Michal Bohdanowicz & Dusan Sajic. (2018) Refractory Palmoplantar Pustular Psoriasis Treated With High-Dose Ustekinumab After Initial Failure. Journal of Cutaneous Medicine and Surgery 23:1, pages 102-104.
Crossref
Kevin K. Wu, Michael P. Lee & Jashin J. Wu. 2019. Clinical Cases in Psoriasis. Clinical Cases in Psoriasis 53 59 .
Joseph F. Merola, Abrar Qureshi & M. Elaine Husni. (2018) Underdiagnosed and undertreated psoriasis: Nuances of treating psoriasis affecting the scalp, face, intertriginous areas, genitals, hands, feet, and nails. Dermatologic Therapy 31:3.
Crossref
R. Bissonnette, R. Haydey, L.A. Rosoph, C.W. Lynde, M. Bukhalo, J.F. Fowler, I. Delorme, A. Gagné-Henley, M. Gooderham, Y. Poulin, K. Barber, P. Jenkin, I. Landells & D.M. Pariser. (2018) Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study. Journal of the European Academy of Dermatology and Venereology 32:3, pages 403-410.
Crossref
Andrew Johnston. 2018. Neutrophilic Dermatoses. Neutrophilic Dermatoses 129 143 .
Jeffrey J. Crowley. 2018. Biologic and Systemic Agents in Dermatology. Biologic and Systemic Agents in Dermatology 159 174 .
Andrew Blauvelt. 2018. Biologic and Systemic Agents in Dermatology. Biologic and Systemic Agents in Dermatology 123 131 .
Isabelle M. Sanchez, Eric Sorenson, Ethan Levin & Wilson Liao. (2017) The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review. Dermatology and Therapy 7:4, pages 425-446.
Crossref
John K. Nia, Peter W. Hashim, Grace Kimmel, Ahmad Aleisa, Ariana C. Farahani & Mark G. Lebwohl. (2017) Update on Ustekinumab for Psoriasis. Current Dermatology Reports 6:1, pages 29-34.
Crossref
Alice Gottlieb, John Sullivan, Martijn van Doorn, Alexey Kubanov, Ruquan You, Anne Parneix, Sophie Hugot & Marina Milutinovic. (2017) Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial. Journal of the American Academy of Dermatology 76:1, pages 70-80.
Crossref
A.-P. Villani & D. Jullien. (2016) Bioterapias en dermatología (cáncer no incluido). EMC - Dermatología 50:4, pages 1-12.
Crossref
Carmine Pinto, Francesca Di Fabio, Gerardo Rosati, Ivan R. Lolli, Enzo M. Ruggeri, Libero Ciuffreda, Daris Ferrari, Giovanni Lo Re, Giovanni Rosti, Paolo Tralongo, Raimondo Ferrara, Oscar Alabiso, Silvana Chiara, Giovanni P. Ianniello, Antonio Frassoldati, Domenico Bilancia, Giovanna A. Campanella, Carlo Signorelli, Patrizia Racca, Elena Benincasa, Maria Elena Stroppolo & Francesco Di Costanzo. (2016) Observational study on quality of life, safety, and effectiveness of first‐line cetuximab plus chemotherapy in KRAS wild‐type metastatic colorectal cancer patients: the ObservEr Study . Cancer Medicine 5:11, pages 3272-3281.
Crossref
Inês Raposo & Tiago Torres. (2016) Palmoplantar Psoriasis and Palmoplantar Pustulosis: Current Treatment and Future Prospects. American Journal of Clinical Dermatology 17:4, pages 349-358.
Crossref
Robert Bissonnette, David M. Pariser, Norman R. Wasel, Joana Goncalves, Robert M. Day, Rongdean Chen & Michael Sebastian. (2016) Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis. Journal of the American Academy of Dermatology 75:1, pages 99-105.
Crossref
P. Weisenseel, D. Wilsmann-Theis, C. Kahl, K. Reich & R. Mössner. (2016) Pustulöse PsoriasisPustular psoriasis. Der Hautarzt 67:6, pages 445-453.
Crossref
Roman Colao, Valerie R. Yanofsky & Mark G. Lebwohl. (2016) Successful Treatment of Palmoplantar Psoriasis Using Combination Acitretin and Apremilast: A Case Report. Journal of Psoriasis and Psoriatic Arthritis 1:2, pages 66-69.
Crossref
George E. FragoulisStefan SiebertIain B. McInnes. (2016) Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases. Annual Review of Medicine 67:1, pages 337-353.
Crossref
John K. Nia & Mark G. Lebwohl. 2016. Therapy for Severe Psoriasis. Therapy for Severe Psoriasis 127 137 .
Alyssa MiceliMegan Rogge & Annette Czernik. (2018) Palmoplantar Psoriasis: A Review of Current Therapy. Psoriasis Forum 21a:1, pages 42-47.
Crossref
Todd E. Schlesinger. 2015. Clinical Dermatology Trials 101. Clinical Dermatology Trials 101 59 72 .
C. Paul, K. Reich, A.B. Gottlieb, U. Mrowietz, S. Philipp, J. Nakayama, E. Harfst, A. Guettner & C. Papavassilis. (2014) Secukinumab improves hand, foot and nail lesions in moderate-to-severe plaque psoriasis: subanalysis of a randomized, double-blind, placebo-controlled, regimen-finding phase 2 trial. Journal of the European Academy of Dermatology and Venereology 28:12, pages 1670-1675.
Crossref
M. Sánchez-Regaña, M.J. Aldunce Soto, I. Belinchón Romero, M. Ribera Pibernat, R.F. Lafuente-Urrez, J.M. Carrascosa Carrillo, C. Ferrándiz Foraster, L. Puig Sanz, E. Daudén Tello, D. Vidal Sarró, R. Ruiz-Villaverde, E. Fonseca Capdevila, M.C. Rodríguez Cerdeira, M.M. Alsina Gibert, E. Herrera Acosta & S.E. Marrón Moya. (2014) Evidence-Based Guidelines of the Spanish Psoriasis Group on the Use of Biologic Therapy in Patients With Psoriasis in Difficult-to-Treat Sites (Nails, Scalp, Palms, and Soles). Actas Dermo-Sifiliográficas (English Edition) 105:10, pages 923-934.
Crossref
A. López-Ferrer & A. Láiz-Alonso. (2014) Psoriatic Arthritis: An Update. Actas Dermo-Sifiliográficas (English Edition) 105:10, pages 913-922.
Crossref
M. Sánchez-Regaña, M.J. Aldunce Soto, I. Belinchón Romero, M. Ribera Pibernat, R.F. Lafuente-Urrez, J.M. Carrascosa Carrillo, C. Ferrándiz Foraster, L. Puig Sanz, E. Daudén Tello, D. Vidal Sarró, R. Ruiz-Villaverde, E. Fonseca Capdevila, M.C. Rodríguez Cerdeira, M.M. Alsina Gibert, E. Herrera Acosta & S.E. Marrón Moya. (2014) Directrices del grupo español de psoriasis (GEP) basadas en la evidencia para el uso de medicamentos biológicos en pacientes con psoriasis en localizaciones de difícil tratamiento (uñas, cuero cabelludo, palmas y plantas). Actas Dermo-Sifiliográficas 105:10, pages 923-934.
Crossref
A. López-Ferrer & A. Laiz-Alonso. (2014) Actualización en artritis psoriásica. Actas Dermo-Sifiliográficas 105:10, pages 913-922.
Crossref
R. Bissonnette, S. Nigen, R.G. Langley, C.W. Lynde, J. Tan, J. Fuentes-Duculan & J.G. Krueger. (2014) Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial. Journal of the European Academy of Dermatology and Venereology 28:10, pages 1298-1305.
Crossref
Trine Bertelsen, Knud Kragballe, Claus Johansen & Lars Iversen. (2014) Efficacy of ustekinumab in palmoplantar pustulosis and palmoplantar pustular psoriasis. International Journal of Dermatology 53:10, pages e464-e466.
Crossref
Y. Poulin, J.J. Crowley, R.G. Langley, K. Unnebrink, O.M. Goldblum & W.C. Valdecantos. (2013) Efficacy of adalimumab across subgroups of patients with moderate‐to‐severe chronic plaque psoriasis of the hands and/or feet: post hoc analysis of REACH. Journal of the European Academy of Dermatology and Venereology 28:7, pages 882-890.
Crossref
Adriane A. Levin & Alice B. Gottlieb. (2014) Specific targeting of interleukin-23p19 as effective treatment for psoriasis. Journal of the American Academy of Dermatology 70:3, pages 555-561.
Crossref
Caitriona Ryan & Craig L. Leonardi. 2014. Advances in Psoriasis. Advances in Psoriasis 197 207 .
Alice Gottlieb & Kirti Narang. (2013) Ustekinumab in the treatment of psoriatic arthritis: latest findings and clinical potential. Therapeutic Advances in Musculoskeletal Disease 5:5, pages 277-285.
Crossref
Neha Garg, Zahi Touma & Christopher T. Ritchlin. (2013) GRAPPA Trainees Symposium 2012: A Report from the GRAPPA 2012 Annual Meeting. The Journal of Rheumatology 40:8, pages 1413-1418.
Crossref
Wolf-Henning Boehncke & Brian Kirby. (2013) GRAPPA Fellows Symposium Adjacent to the European Academy of Dermatology and Venerology Meeting, Verona, 2012: A Meeting Report. The Journal of Rheumatology 40:8, pages 1410-1412.
Crossref
C. Morales-Múnera, E. Vilarrasa & L. Puig. (2013) Efficacy of ustekinumab in refractory palmoplantar pustular psoriasis. British Journal of Dermatology 168:4, pages 820-824.
Crossref
Noori Kim & Alice B. Gottlieb. (2012) Psoriasis: Ustekinumab and Other Biologics in the Pipeline. Current Dermatology Reports 1:3, pages 108-114.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.